drugset / Trial / NCT01912573

Nasal Naloxone for Narcotic Overdose

NCT01912573

Phase 4 Unknown 236 enrolled Judith Feinberg
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to determine if nasal naloxone is inferior to standard care for naloxone administration in a pre-hospital setting. Ambulance squads in Adams, Clermont, and Scioto counties in southern Ohio will be randomized to provide either standard care or nasal (IN) naloxone as the initial response to a suspected opioid overdose. Standard care includes administration of naloxone by intravenous (IV), intramuscular (IM) or intraosseus (IO) methods.

Timeline

Start
2013-09
Primary completion
2014-09
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule Intranasal

Indications

No indication recorded.